The Peter Attia Drive

#65 - Rick Doblin, Ph.D.: MDMA— the creation, scheduling, toxicity, therapeutic use, and changing public opinion of what is possibly the single most important synthetic molecule ever created by our species

18 snips
Aug 5, 2019
Rick Doblin, founder of MAPS, shares his groundbreaking insights on MDMA, revealing its potential to revolutionize PTSD treatment. He dives into the molecule's history, the obstacles leading to its criminalization, and his passionate advocacy for its therapeutic use. The conversation dissects myths surrounding MDMA's safety and touches on the intricacies of current FDA trials for MDMA therapy. With compelling stories and a vision for a compassionate future, this dialogue underscores the importance of reevaluating drug classifications to embrace psychedelic healing.
Ask episode
AI Snips
Chapters
Books
Transcript
Episode notes
ANECDOTE

Laura Huxley's Influence

  • Laura Huxley's interest in Rick Doblin's work arose from a letter he wrote to Robert Muller.
  • This led to Doblin's involvement in early discussions about protecting MDMA's therapeutic use.
ANECDOTE

The Rise of Ecstasy

  • Michael Klieg, involved in the early MDMA scene, marketed it as "ecstasy".
  • This public use raised concerns among those interested in its therapeutic potential.
ANECDOTE

Octopuses on MDMA

  • A study at Johns Hopkins showed octopuses react to MDMA similarly to humans.
  • This suggests MDMA acts on primitive brain areas, predating human-octopus divergence.
Get the Snipd Podcast app to discover more snips from this episode
Get the app